furosemide has been researched along with sacubitril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beavers, JC; Orvin, NJ; Russell, SD | 1 |
| Chatur, S; Claggett, BL; Desai, AS; Jering, K; Lefkowitz, M; McMurray, JJV; Pfeffer, MA; Solomon, SD; Vaduganathan, M; Vardeny, O | 1 |
1 trial(s) available for furosemide and sacubitril
| Article | Year |
|---|---|
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diuretics; Drug Combinations; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Tetrazoles; Valsartan | 2023 |
1 other study(ies) available for furosemide and sacubitril
| Article | Year |
|---|---|
Acute Diuretic-Sparing Effects of Sacubitril-Valsartan: Staying in the Loop.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Diuretics; Drug Combinations; Furosemide; Heart Failure; Humans; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Tetrazoles; Valsartan; Ventricular Dysfunction, Left | 2022 |